跳至主要内容
临床试验/NCT05662306
NCT05662306
终止
4 期

Comprehensive Treatment of Early Course Schizophrenia: A Nonrandomized Study of Long Acting Injectable Antipsychotic Medication Combined With Cognitive and Functional Skills Training

University of Miami1 个研究点 分布在 1 个国家目标入组 1 人2024年1月23日

概览

阶段
4 期
干预措施
Aripiprazole Lauroxil
疾病 / 适应症
Schizophrenia
发起方
University of Miami
入组人数
1
试验地点
1
主要终点
The Percentage of Participants Who Develop Sustained Remission of Symptoms of Schizophrenia as Measured as Having a Score of 3 or Less on All 6 Critical Items From the Positive and Negative Syndrome Scale (PANSS)
状态
终止
最后更新
2个月前

概览

简要总结

The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.

注册库
clinicaltrials.gov
开始日期
2024年1月23日
结束日期
2025年3月3日
最后更新
2个月前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Principal Investigator
主要研究者

Dante Durand

Associate Professor of Psychiatry

University of Miami

入排标准

入选标准

  • Diagnosis of schizophrenia
  • Current Hospitalization or outpatient relapse
  • Fewer than four previous admissions
  • Willing to accept long-acting injectable treatment and participate in rehabilitation

排除标准

  • Primary diagnosis other than schizophrenia
  • Prior Long Acting Injectable treatment
  • Current Suicide Risk
  • Hypersensitivity to Aripiprazole
  • Positive illicit drug screen other than cannabis (rescreening allowed in 4 weeks for drug positive cases)
  • Unable to give personal informed consent
  • History of treatment resistance as evidenced by clozapine treatment
  • Unable to stop treatment with medications that are strong Cytochrome (CYP) 2D6 or CYP 3A4 inhibitors and or strong CYP3A4 inducers (2.3, 7.1) for at 14 days prior to initiation.

研究组 & 干预措施

Aripiprazole and Computerized Cognitive and Functional Skills Training Group

Participants in this arm will receive long-acting injectable aripiprazole every 2 months formulation for 12 consecutive months. Participants in this arm will also receive Computerized cognitive and functional skills training during the first 12 weeks of study participation.

干预措施: Aripiprazole Lauroxil

Aripiprazole and Computerized Cognitive and Functional Skills Training Group

Participants in this arm will receive long-acting injectable aripiprazole every 2 months formulation for 12 consecutive months. Participants in this arm will also receive Computerized cognitive and functional skills training during the first 12 weeks of study participation.

干预措施: Computerized cognitive and functional skills training

结局指标

主要结局

The Percentage of Participants Who Develop Sustained Remission of Symptoms of Schizophrenia as Measured as Having a Score of 3 or Less on All 6 Critical Items From the Positive and Negative Syndrome Scale (PANSS)

时间窗: 6 months

PANSS has 6 critical items with each item being scored from 1 to 7 with the higher score indicating more severe symptoms. A score of 3 or less on all six critical items defines the presence of remission.

研究点 (1)

Loading locations...

相似试验